MAXHEALTH Share Price, Analysis & Fundamentals

High trading activity and short-term strength are overshadowed by the stock's struggle below its 50-day EMA, signaling a neutral trend.

The stock shows a mixed technical outlook, with positive short-term returns of 7.20% over 5 days and a bullish momentum indicated by an RSI of 61.35 and a MACD signal. However, it is trading below the 50-day EMA and near the upper Bollinger Band, suggesting elevated volatility and a neutral trend alignment.
Fundamentally, the company reported revenue of ₹2068 Cr for December 2025, up 10.707% year-over-year, but down 3.138% quarter-over-quarter. Net profit saw a significant YoY increase of 25.941% to ₹301 Cr, despite a 38.697% QoQ decrease, with EPS at ₹3.09.
Analysts maintain a predominantly bullish stance, with 77.27% recommending a 'Buy' or 'Strong Buy', and this distribution has remained stable over the past month, indicating consistent analyst confidence.
Institutional investors, including FIIs and DIIs, hold a substantial 71.75% of the company's shares. There was a slight reallocation within institutions, with FIIs reducing their stake by 1.25% and DIIs increasing theirs by 1.17% in the last quarter.

Short-term returns show a positive trend over 5 days (7.20%) and 1 month (4.49%), but a negative 3-month return (-1.29%).
The stock is trading above its 9-day and 21-day EMAs, with a positive price vs. 21-day EMA percentage (3.12%), indicating a short-term bullish trend. However, it is below the 50-day EMA, and the trend alignment score is neutral.
Momentum is strong, with an RSI of 61.35 and a bullish MACD signal. The RSI is in the 86.81 percentile over the past year.
Volatility is elevated, with the price positioned at 96.86% of the Bollinger Band width, suggesting it is trading near the upper band. The annualized daily volatility is 23.84%.
The stock is trading 22.01% below its 52-week high and 8.95% above its 52-week low, with a current drawdown of -22.01%.

The stock exhibits a mixed technical picture. While short-term returns and momentum indicators like RSI and MACD are positive, suggesting potential upward movement, the price is trading below the 50-day EMA and the trend alignment score is neutral. The stock is also trading near the upper Bollinger Band, indicating elevated volatility. The current position relative to 52-week highs and lows, along with the drawdown, suggests that while there's some recovery, it remains significantly below its peak.

The company reported revenue of ₹2068 Cr in Dec 2025, with a QoQ change of -3.138% and a YoY change of 10.707%.
Net profit for the latest quarter was ₹301 Cr, showing a QoQ decrease of -38.697% and a YoY increase of 25.941%.
EPS stood at ₹3.09, marking a QoQ decline of -38.812% and a YoY growth of 25.61%.
Profit before tax experienced a QoQ decrease of -18.161% and a YoY increase of 18.123%.